Cipla500087Pharmaceuticals
Cipla reported Q2 results with revenue of 7,404 crore rupees, down 2.4% year-on-year, net profit down 35%, though EBITDA margin beat estimates
By ScoutQuest · · 1 min read
- Q2 revenue
- 7,404 crore rupees
- Revenue YoY change
- -2.4 percent
- EBITDA margin actual
- 18.7 percent
- EBITDA margin estimate
- 18.3 percent
- Net profit YoY change
- -35 percent
Heard on business television between 13:23:29 - 13:26:29 IST.
- Revenue came in at 7,404 crore rupees, slightly below Live TV News Channel poll estimates, down 2.4% year-on-year.
- EBITDA margin was 18.7% versus poll estimate of 18.3%, beating expectations.
- Net profit fell 35% year-on-year, also coming in below estimates.
- Stock was largely flat with a mild recovery into positive territory after the results.
Watch at source
behind live
- 1Open on YouTube
- 2Drag the seek bar left
- 3Watch this moment
Also from Cipla
Cipla reported modest Q2 numbers but maintained its US revenue and EBITDA margin guidance, prompting mixed brokerage reactions
28 Oct 2026
Cipla posts audio recording of Q2/H1 FY27 earnings conference call on its website
27 Oct 2026
Cipla's Q2 results were largely in line with estimates, with a dip in profit and muted US sales due to supply issues
27 Oct 2026
Source: Live TV News Channel · 27 Oct 2026
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.